Michelle Doig - Profile and Investment Details

Investor Profile

Michelle Doig is a Venture Capital, Private Equity Firm, Investor based in Toronto, Ontario, Canada with a diverse investment portfolio that includes companies such as FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua, Syros Pharmaceuticals, Jounce Therapeutics, Hydrocision, Atea Pharmaceuticals, Artios Pharma Ltd, BridgeBio Oncology Therapeutics, Develogen AG, eTheRNA immunotherapies, LEXEO Therapeutics, Telesta Therapeutics, Prevail Therapeutics, Nuvation Bio, Editas Medicine, Ardana Bioscience, Orqis Medical, XTuit Pharmaceuticals, Scorpion Therapeutics, Alpine Immune Sciences, GelSight, Dicerna Pharmaceuticals, First Wave Bio, Morphic Therapeutic, Sana Biotechnology, Adagio Therapeutics, Intarcia Therapeutics, Eurobio-Scientific, Andrew Alliance, ImpactRx, BioSilta, Ikena Oncology, ESSA Pharma, Celletra, Median Technologies, Translate BioCropDesign, CymaBay Therapeutics, Exenta, Inc., Third Rock Ventures, Neurotech, Aquarius Technologies, Replimune Group, Elixir Pharmaceuticals, Checkmate Pharmaceuticals, Omega Alpha SPAC, Imago BioSciences, Icosavax, Visterra, SpineVision, Achaogen, OnPath Technologies, Amunix, Kronos Bio, Immunic, Gossamer Bio, Anaconda BioMed, Kuros Biosciences, JenaValve Technology, Trevi Therapeutics, Egalet, Paratek Pharmaceuticals, Arrakis Therapeutics, DBV Technologies, Kezar Life Sciences, Sienna Biopharmaceuticals, Oxagen, Evotec, Beam Therapeutics, Senti Biosciences, IFM Therapeutics, Chord Therapeutics, Endeavor BioMedicines, ObsEva, Arcutis Biotherapeutics, NeuroVision Imaging, Bicara Therapeutics, . Over time, Michelle Doig has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Michelle Doig is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Genetics, Wellness, Women Founded, Rare Diseases, Life Science, Portfolio Management, Information Technology (IT), Finance, Biotechnology, Medical Devices, Drug Development, Electronic Health Records (EHR), Genomics, Health and Hospital Services, Precision Medicine, Digital Health, Developer Tools, Travel, Medical, B2B, Therapeutics, Pharmaceuticals, Healthcare Technology, Oncology may find it worthwhile to explore potential connections with Michelle Doig, as their portfolio suggests a familiarity and interest in this area.

Understanding Michelle Doig’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.